DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed

Rhea-AI Filing Summary

DNA filed a Form 144 reporting proposed sales of Class A shares. The notice lists a proposed sale of 324 Class A shares tied to restricted stock vesting dated 04/16/2026. It also discloses recent reported sales by Steve Coen: 972 shares on 01/20/2026, 708 shares on 03/16/2026, and 33,171 shares on 04/13/2026, each with the corresponding proceeds shown in the filing.

Key Figures

Proposed sale tied to vesting: 324 shares Sale by Steve Coen: 972 shares Sale by Steve Coen: 708 shares +1 more

4 metrics

Proposed sale tied to vesting 324 shares Restricted Stock Vesting dated 04/16/2026

Sale by Steve Coen 972 shares Sale dated 01/20/2026; proceeds $8,667.23

Sale by Steve Coen 708 shares Sale dated 03/16/2026; proceeds $4,768.52

Sale by Steve Coen 33,171 shares Sale dated 04/13/2026; proceeds $212,762.11

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"Class A | 04/16/2026 | Restricted Stock Vesting"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Securities To Be Sold | Class A | 04/16/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"Securities To Be Sold | 04/16/2026 | ... | Compensation"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	324	2576.36	49941878	04/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	04/16/2026	Restricted Stock Vesting	Issuer			324	04/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	01/20/2026	972	8667.23
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	03/16/2026	708	4768.52
Steve Coen 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/13/2026	33171	212762.11

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does DNA's Form 144 disclose?

It discloses proposed sales and recent transactions in Class A shares by insiders and brokers. The filing lists a proposed sale of 324 Class A shares tied to restricted stock vesting on 04/16/2026 and three recent sales by Steve Coen on 01/20/2026, 03/16/2026, and 04/13/2026.

How many shares does Steve Coen report selling in recent filings (DNA)?

Steve Coen reported three recent sales totaling specific share counts on three dates. The filing shows 972 shares on 01/20/2026, 708 shares on 03/16/2026, and 33,171 shares on 04/13/2026, with dollar proceeds listed alongside each sale.

What is the listed reason for the 324 Class A shares to be sold (DNA)?

The 324 Class A shares are tied to restricted stock vesting and labeled as compensation. The filing lists the transaction date as 04/16/2026 and identifies the issuer as the source for those vested shares.

Does the Form 144 show proceeds for each sale (DNA)?

Yes, proceeds are shown alongside each listed sale in dollar amounts. For example, the filing pairs 972 shares with $8,667.23, 708 shares with $4,768.52, and 33,171 shares with $212,762.11 as reported proceeds.